Welcome to our dedicated page for Claritev SEC filings (Ticker: MPLNW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Claritev's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Claritev's regulatory disclosures and financial reporting.
Albinson Brock reported acquisition or exercise transactions in this Form 4 filing.
Claritev Corp senior vice president and chief accounting officer Albinson Brock received a grant of 2,956 restricted stock units tied to Class A common stock. These units were awarded at no cash cost as part of his compensation.
The RSUs will vest in four equal installments of 25% each on March 31 of 2027, 2028, 2029, and 2030, aligning incentives over several years. After this award, Brock directly holds 30,193 shares of Claritev common stock.
Claritev Corporation is calling a virtual annual meeting on April 29, 2026 for holders of Class A stock as of March 6, 2026. Stockholders are being asked to elect four Class III directors, ratify PricewaterhouseCoopers LLP as auditor, approve executive pay on an advisory basis, and approve an amendment increasing shares under the 2020 Omnibus Incentive Plan.
Claritev positions itself as a healthcare technology, data and insights company focused on transparency and affordability. Management highlights a 2025 “Year of the Turn,” returning to revenue growth, stronger adjusted EBITDA and free cash flow, and more than $67 million in new annual contract value. The company processed $179.8 billion in medical charges, identifying $25.0 billion in potential cost savings, and reports 2025 total stockholder return of 189%.
The executive pay program centers on market-competitive salaries, annual cash incentives and equity awards. 2025 bonuses paid at 110% of target after the leadership team requested negative discretion to shift more of the pool to other employees. From 2026, 25% of long-term incentives for executives will be performance stock units tied to unlevered free cash flow. The proxy also details a classified 11-seat board with a lead independent director, extensive healthcare and technology experience, and committee oversight of risk, including cybersecurity and artificial intelligence, alongside a sustainability working group and plans for a 2025 Corporate Responsibility Report in the third quarter of 2026.
Claritev Corporation used its 2026 Investor Day to outline its strategy, financial guidance, and long-term goals for its healthcare cost-management and analytics platform. Management highlighted core businesses in claims intelligence, network solutions, and payment and revenue integrity, plus growth in data and analytics, international markets, and services.
For FY 2026, Claritev projects revenue of $980 million to $1 billion and Adjusted EBITDA of $605 million to $615 million, with total capital spend of $160 million to $170 million, an effective tax rate of 24% to 28%, and free cash flow of $0 to $10 million.
The company’s Vision 2030 model contemplates revenue of $1.3 billion and Adjusted EBITDA of $800 million, targeting an Adjusted EBITDA margin of roughly 61% to 64% and a path to reduce net leverage toward about 5.0x while increasing levered free cash flow.
Claritev Corp executive vice president and CFO Garis Douglas Michael bought shares of his company in the open market. On March 16, 2026, he purchased 1,300 shares of Class A common stock at $17.69 per share, bringing his direct holdings to 206,152 shares.
He also reports indirect ownership of additional Class A shares through retirement accounts, including 19,927 shares in his spouse's IRA and 45,810 shares in his own IRA, along with smaller positions in IRAs for his daughter and son. The filing shows a net-buy transaction with no reported sales.
Claritev Corp executive vice president and Chief Digital Officer Kim Michael bought 15,000 shares of Class A common stock in an open-market transaction at $16.50 per share on 2026-03-12, increasing direct ownership to 182,878 shares.
Claritev Corp SVP and General Counsel Tara O'Neil reported equity compensation activity and related tax withholdings. She received a grant of 18,130 shares of Class A common stock as restricted stock units at no cost, increasing her direct holdings to 43,113 shares.
To cover taxes on previously granted restricted stock units vesting on March 1 in 2022, 2023, 2024, and 2025, a total of 2,216 Class A shares were disposed of through tax-withholding transactions at $13.47 per share. In addition, 6,967 cash-settled restricted stock units granted in 2025 were settled in cash as 50% vested on March 1, 2026.
Claritev Corp director White Dale A. reported tax-related share dispositions tied to vesting restricted stock units. On March 1, 2026, a total of 14,158 shares of Class A common stock were withheld at $13.47 per share to cover tax obligations on RSU awards granted in 2022 and 2023.
After these tax-withholding dispositions, White directly holds 145,922 shares of Claritev Class A common stock. An additional 201,652 shares are listed as indirectly held by a trust. The transactions were not recorded as open-market purchases or sales but as payment of tax liabilities by delivering shares.
Claritev Corp EVP & CFO Garis Douglas Michael reported several equity-related transactions in Claritev Class A common stock and related units on March 1, 2026. He disposed of 25,488 cash-settled restricted stock units back to the issuer following vesting of cRSUs granted on March 1, 2025. He also had 5,331 Class A shares withheld to cover taxes tied to vesting of prior restricted stock units, and received a grant of 66,322 restricted stock units that vest in four equal annual installments on March 1 of 2027, 2028, 2029, and 2030. After these transactions, he reported 204,852 Class A shares held directly, plus additional indirect holdings in Individual Retirement Accounts for himself, his spouse, and children.
Claritev Corp EVP and Chief Digital Officer Kim Michael reported several equity-related transactions on March 1, 2026. The filing shows a grant of 34,487 shares of Class A common stock as restricted stock units that will vest 25% each year on March 1, 2027, 2028, 2029, and 2030. The company also withheld multiple small blocks of Class A common stock to cover taxes due on previously granted restricted stock units that vested on March 1 of 2022, 2023, 2024, and 2025. In addition, cash-settled restricted stock units granted on March 1, 2025 partially vested and were settled in cash, reducing the number of those units held.
Claritev Corp EVP and COO Jerome Hogge reported equity award and related tax dispositions. On March 1, 2026, he received 66,322 shares of Class A common stock as a grant. The filing also shows share dispositions tied to tax withholding and the cash settlement of previously granted cash-settled RSUs.